| Authors: |
Bellanti F; Division of Pharmacology, Leiden Academic Centre for Drug Research, Leiden, The Netherlands., Del Vecchio GC; Azienda Ospedaliera Universitaria Consorziale, Policlinico di Bari, Bari, Italy., Putti MC; Azienda Ospedaliera di Padova, Clinica di Oncoematologia Pediatrica, Padova, Italy., Cosmi C; Azienda Ospedaliera Universitaria, Policlinico di Sassari,, Sassari, Italy., Fotzi I; Azienda Ospedaliera Universitaria, Policlinico di Sassari,, Sassari, Italy., Bakshi SD; Division of Pharmacology, Leiden Academic Centre for Drug Research, Leiden, The Netherlands., Danhof M; Division of Pharmacology, Leiden Academic Centre for Drug Research, Leiden, The Netherlands., Della Pasqua O; Division of Pharmacology, Leiden Academic Centre for Drug Research, Leiden, The Netherlands. o.dellapasqua@ucl.ac.uk.; Clinical Pharmacology & Therapeutics, University College London, BMA House, Tavistock Square, WC1H 9JP, London, UK. o.dellapasqua@ucl.ac.uk.; Clinical Pharmacology Modelling & Simulation, GlaxoSmithKline, Stockley Park, Uxbridge, UK. o.dellapasqua@ucl.ac.uk. |